(Q24546050)

1

0 references

Bret K Purcell

2

0 references

James V Lawler

3

0 references

Elizabeth K Leffel

4

0 references

Pedro Rico

5

0 references

Christopher S Gamble

6

0 references

Nancy A Twenhafel

7

0 references

Bruce E Ivins

8

0 references

Henry S Heine

9

0 references

Ryan Sheeler

10

0 references

Mary E Wright

11

0 references

Arthur M Friedlander

Proceedings of the National Academy of Sciences of the United States of America

12

0 references

language of work or name

English

0 references

publication date

16 May 2006

0 references

published in

0 references

volume

103

0 references

issue

20

0 references

page(s)

7813-6

0 references

cites work

Specific, sensitive, and quantitative enzyme-linked immunosorbent assay for human immunoglobulin G antibodies to anthrax toxin protective antigen

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472527

Modeling the optimum duration of antibiotic prophylaxis in an anthrax outbreak

24 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472527

Antimicrobial postexposure prophylaxis for anthrax: adverse events and adherence

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472527

Anthrax: clinical features, pathogenesis, and potential biological warfare threat.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472527

Observations on the prophylaxis of experimental pulmonary anthrax in the monkey

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472527

Treatment of anthrax infection with combination of ciprofloxacin and antibodies to protective antigen of Bacillus anthracis

30 May 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0602748103

Penicillin andB. anthracis

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0602748103

Update: Investigation of bioterrorism-related anthrax, 2001.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1472527

Anthrax vaccine: evidence for safety and efficacy against inhalational anthrax

28 November 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0602748103

Postexposure prophylaxis against experimental inhalation anthrax

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0602748103

Serum concentrations of penicillin, doxycycline, and ciprofloxacin during prolonged therapy in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0602748103

Comparative efficacy of experimental anthrax vaccine candidates against inhalation anthrax in rhesus macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1073%2FPNAS.0602748103

21 January 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/16672361

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Pathology of experimental inhalation anthrax in the rhesus monkey

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16672361